The Eighth Annual International Employment Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Eighth Annual International Employment Survey


Pharmaceutical Technology



Figure 6: A steady, and almost predictable, increase in annual compensation continues to contribute to overall employment stability and security.
These initiatives are not the only government decisions affecting pharma workers. "The biggest change in how we do business is [the] Sarbanes-Oxley [Act]," says Allen Bokser, director of analytical R&D at Hollis-Eden Pharmaceuticals (San Diego, CA, http://www.hollisedin.com/), a virtual biotech company that relies entirely on contract testing and manufacturing services. In many cases, that legislation has resulted in extra documentation and extra time needed to complete routine tasks such as obtaining contracts and making purchase orders, especially when conducting business with international service providers.

Summary

The pharmaceutical industry continues to provide a stable job market. Overall, US respondents have continued to see a steady increase in their annual salaries (see Figure 6), including a 5% increase over 2004. Women in aggregate continue to earn about 20% less than their male colleagues. Although there is a 6% increase in those who foresee a job change within the next 12 months, nearly 70% of all employees agree or strongly agree their jobs are secure.

Reference

1. US Department of Labor and the US Bureau of Labor Statistics "Highlights of Women's Earnings in 2004," report 987, Sept. 2005, http://stats.bls.gov/.

Photos courtesy of Sartorius Corporation.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here